ÂÜÀòÂÒÂ×

Christopher King is a skilled professional in the field of business development and scientific research, currently serving as the Business Development Services Manager at Fusion Antibodies since February 2021. Prior to this role, Christopher held various positions at Fusion Antibodies, including Officer - Scientific Business Development and Principal Scientist. Before joining Fusion Antibodies, Christopher worked as an Extraction Scientist at Randox from November 2019 to February 2021. Christopher holds a Bachelor's degree in Microbiology from Queen's University Belfast and a Higher National Diploma in Applied Medical Sciences from South Eastern Regional College.